Urine calcium and deoxypyridinoline in assessment of response to local radiation therapy for metastatic bone disease

TOPKAN E., KARAOĞLU A.

Journal of Experimental & Clinical Cancer Research, cilt.26, sa.4, ss.553-559, 2007 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 4
  • Basım Tarihi: 2007
  • Dergi Adı: Journal of Experimental & Clinical Cancer Research
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.553-559
  • Anahtar Kelimeler: urine calcium, deoxypyridinoline, palliative radiotherapy, PYRIDINIUM CROSS-LINKS, DOSE-RANGING TRIAL, BREAST-CANCER, BIOCHEMICAL MARKERS, PAMIDRONATE TREATMENT, DISODIUM PAMIDRONATE, MULTIPLE-MYELOMA, ZOLEDRONIC ACID, PHASE-I, RESORPTION
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

To evaluate the predictability of urine calcium (Ca2+) and deoxypyridinoline (DPD) in the assessment of response to palliative radiation therapy (RT) for metastatic bone disease.